견적문의

NEW YORK--( / )--Morgan Stanley (NYSE: MS) today announced the 2023 global cohort of the , with 23 companies selected across North America and Europe, the Middle East and Africa (EMEA), double the size of previous cohorts. The Lab offers a five-month in-house accelerator program for underrepresented founders of technology and technology-enabled startups in the post-seed to Series A funding round stage.

Chosen from over 7,900 applicants - more than three times last year’s pool - the selected startups represent a range of disruptive technologies in industries including healthcare, sustainable solutions, customer service, supply chain, recruiting and cybersecurity. Companies in the cohort receive a $250,000 investment (￡250,000 in EMEA) from Morgan Stanley, as well as a variety of mentorship opportunities and business-growth resources from Morgan Stanley’s ecosystem of internal and external partners.

“We are proud to welcome the Lab’s largest cohort yet, marking our continued efforts to create a more equitable investment landscape for overlooked entrepreneurs worldwide,” said Selma Bueno, Global Head of the Morgan Stanley Inclusive Ventures Group. “We are working to bridge the investment gap for underserved founders and to help correct documented market imbalances.”

The selected companies in the 2023 global cohort include the following:

· Ad Auris empowers marketing teams, publishers and content creators to repurpose written content into high-quality audio to reach an audience of listeners (Canada)

· Automated Architecture provides the technological infrastructure for a distributed robotic micro-factory network producing sustainable timber housing (UK)

· Bidrento offers an all-in-one solution for tenant experience and rental property management, helping to save time and money while also reducing CO2 emissions in real estate (Estonia)

· ByFusion provides a zero waste landfill diversion platform to transform non-recyclable plastic waste into reusable building materials (US)

· Cult Mia is an online fashion marketplace for sustainable and ethical brands from around the world (UK)

· DotLab develops breakthrough, actionable AI and ML technologies that lead to better health outcomes for women, starting with the diagnosis of endometriosis (US)

· eBanqo offers businesses an omnichannel platform to drive customer engagement and support (Nigeria)

· Encounter AI uses digital conversational ordering solutions to provide faster, friendlier and more efficient service to customers, restaurants and retailers (US)

· FLUIX Inc. enterprise AI software saves critical infrastructure on energy costs by integrating and optimizing facility systems (US)

· GigBridge is an online platform for construction companies to hire, onboard and pay their workforce all in one place (UK)

· Health in Her HUE connects Black women and women of color to culturally sensitive healthcare providers, health content and community support through a digital platform (US)

· Inicio AI delivers a virtually guided affordability assessment to help organizations save contact center costs while improving their end customer experience (UK)

· MEDIjobs is the first virtual recruiter for the healthcare industry, filling more than 55 types of positions at a rate five times faster than a human would (US)

· Nopalera is a collection of bath and body products powered by Mexico’s nopal cactus - an ancient symbol of Mexican culture (US)

· OKO offers affordable and inclusive crop insurance to farmers in emerging countries using satellite weather data and mobile payment technologies (Israel)

· Oppos provides robust cybersecurity and compliance security solutions for businesses, safeguarding data confidentiality, integrity, and availability (Canada)

· Partsimony enables organizations to build intelligent manufacturing supply chains that are more resilient and sustainable by unifying engineering and supply chain data (US)

· Ridelink leverages technology to enable small and medium-sized businesses to move cargo in Uganda and cross-border in six neighboring countries (Uganda)

· serviceMob is an AI & ML-powered customer service analytics platform that helps businesses optimize operations and improve the customer experience (US)

· Stak Mobility facilitates widespread urban electric vehicle adoption by merging space-saving vertical parking automation with fully integrated EV charging and a seamless mobile self-service experience (US)

· Tall Poppy is a digital security company protecting employees and public facing teams from online threats (US)

· Twipes uses bio-tech to produce flushable, biodegradable wet wipes that break down in water in three hours and biodegrade in landfills in seven days (US)

· Unfabled is a consumer health platform that delivers personalized solutions for women by matching them with health and wellness products (UK)

“We are thrilled to bring our unique accelerator program to more entrepreneurs globally, including our first participants from Africa and the Middle East,” said Sanghamitra Karra, EMEA Head of the Inclusive Ventures Group. “It is highly rewarding to work closely with founders to take their game-changing technologies to scale and help set them up for continued success.”

“By providing these promising startups with much-needed capital, a tailored curriculum and access to investors within and beyond the Firm’s far-reaching network, we aim to ensure that more underrepresented founders can succeed,” said LaToya Wilson, Americas Head of the Inclusive Ventures Group.

Programming will run through February 2024 and culminate in a global Demo Day, when participating companies will present to potential investors, business partners and customers.

The Inclusive Ventures Lab has won multiple Gold Anthem Awards, including Most Impactful Corporate Initiative in 2022 and Corporate Social Responsibility in 2023. The program was also listed as one of Global Finance’s Best Innovation Labs of 2023.

About the Morgan Stanley Inclusive Ventures Lab

The Morgan Stanley Inclusive Ventures Lab (MSIVL) is an intensive five-month in-house accelerator program designed to help further develop and scale startups, culminating in a showcase presentation and Demo Day to the investor community. Morgan Stanley launched MSIVL, formerly called the Multicultural Innovation Lab, in 2017 in order to address inequities in funding of underrepresented founders, which our research shows equals over four trillion dollars in unrealized returns.

About Morgan Stanley

Morgan Stanley (NYSE: MS) is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 countries, the Firm’s employees serve clients worldwide including corporations, governments, institutions and individuals. For further information about Morgan Stanley, please visit .

View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network

GENEVA--( / )--The Wyss Center, a leading 텀블러/인스타그램 GENEVA--(research center dedicated to innovating and accelerating technologies and therapies for neurological and mental health disorders, is 펀비넷 www.7m.cn pleased to announce the appointment of Craig Cook, 망성면성인게임장 별밤TV MD, MBA, to the leadership team as Head of Business Development and Licensing. Dr. Cook brings more than 25 years of impressive executive leadership and entrepreneurial expertise in the fields of biotech, medtech and clinical medicine.

“The addition of Craig to the Wyss Center team comes at a pivotal time,” said Erwin Bottinger, MD, CEO of the Wyss Center, “Craig brings a wealth of 펀비넷 띵동라이브스코어 experience in translating medical technologies and therapies into clinical impact. His 여성성기구느낌 “Thetrack record of business development and licensing within the healthcare sector as well as his deep understanding of the complex landscape of neurological and mental health disorders will be instrumental in advancing the Wyss Center’s strategic priorities and expanding the reach of our scientific advancements and technologies.”

“I am thrilled to join 위즈토렌트 “IWyss Center and contribute to its 펀비넷 groundbreaking work in revolutionizing the treatment 펀비넷 김여림 landscape for neurological and mental health disorders,” said Craig Cook, MD, MBA. “I look forward to building on the Center’s impressive neuroscience and neurotechnology portfolio, and forging lasting partnerships and ventures that will advance the mission of the Center and drive technologies and therapies from research into valuable clinical and commercial 망성면성인게임장 실시간프로토 opportunities that can significantly impact patient’s lives.”

Dr. Cook joins the Wyss Center after an outstanding career in the pharmaceutical, biotech, and medtech sectors. His achievements include appointments to CEO positions in publicly listed biotech companies as well as assuming key roles at the C-level, board, and 펀비넷 야구토토스페셜 founder levels in multiple life science ventures. Dr. Cook‘s extensive track record 망성면성인게임장 허윤미 complements the Wyss Center’s commitment to neurological and 펀비넷 mental health, strengthening its science and technology portfolio.

Notable roles in his career include serving as Chairman of PreciHealth, leading the development of next-generation medical diagnostics; additionally he served as CEO of Herantis Pharma Plc specializing in neurodegenerative diseases, and CEO of Midatech Pharma Plc focusing 펀비넷 축구공 on therapies for 고18 Notablebrain tumors in adults and pediatrics. Dr. Cook has also held key positions at multinational biotech and 펀비넷 베스퍼 pharmaceutical companies such as Serono, Novartis, and Eli Lilly, with a specific emphasis on CNS and mental health. Furthermore, he has successfully founded or co-founded impactful ventures including SedateUK, a pioneer in anesthesia innovation and training; Longevity IQ, promoting an evidence-based scientific approach in preventive medicine and neurological and mental well-being; and SpaceCode Healthcare, a pioneering life science technology company.

Dr. Cook's 펀비넷 토토잘하는법 educational qualifications include an 펀비넷 토토핸디캡 MD from Wits University in South 펀비넷 토토갤러리 Africa, an MBA from the London Business School, an MSc in Translational Medicine from Kings College 망성면성인게임장 야풀 London, a DA in Anesthesiology, and a BSc in Pharmacology.

About the 펀비넷 토토스포츠 Wyss Center 펀비넷 for Bio and Neuroengineering, Geneva, Switzerland

The 펀비넷 토토싸이트 Wyss Center is an independent, non-profit, 펀비넷 Busta-Bet research organization that 누드갤러리 Theand accelerates technologies and therapies to transform the lives of people 망성면성인게임장 with neurological and mental health disorders.

The 중화산동홀덤 Thepursues transformational technologies in artificial intelligence, bio- 펀비넷 더킹카지노 and neuroengineering to restore essential neural functions and deliver precision therapeutics for people with debilitating neurological and mental health disorders.

Based at Campus Biotech in Geneva, Switzerland, the Wyss Center 펀비넷 레드삭스 partners LGjhtYTK Basedfaculty, clinicians and industry, in Switzerland 펀비넷 프리존 and internationally, to drive innovation and maximize clinical impact. 펀비넷 해외배팅

The Wyss Center was established by a generous donation from the Swiss 펀비넷 해외승무패 entrepreneur and philanthropist Hansjorg Wyss in 2014. Additional resources from funding 여산면성인게임장 Theand other sources help the Wyss Center achieve its mission.

View 펀비넷 source version on businesswire.com:(Photo: Wyss Center for Bio and Neuroengineering)